Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLCL/Fg dressing for diabetic foot ulcers
NCT06014437Phase 4Unknown
- Start
- Mar 2023
- Primary completion
- Jan 2024
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in diabetic foot ulcer (DFU) (2 arms). Primary endpoint: Incidence of complete wound closure at 12 weeks. Status: unknown.
02
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT06014437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06014437.